A Twenty Years Epidemiology Study of 2nd Hematological Malignancies Post to the Initial Tumor Treatment: Report from Southern China Single Cancer Group

Conclusion: In general, the outcome of secondary hematological tumors is poor. However, patients who did not receive chemo- or radiotherapy during the initial tumor treatment had a longer survival than those who did. The risk factors, potentially type of chemo-agent and cumulative dosage of drugs, which may contribute to the occurrence of 2nd hematological malignancies, should be fully explored before formulating the initial tumor treatment plan.DisclosuresNo relevant conflicts of interest to declare.
Source: Blood - Category: Hematology Authors: Tags: 904. Outcomes Research-Malignant Conditions Source Type: research